Chapter 2: Electronic submission of information on medicinal products by MAH of the Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA

Chapter 2: Electronic submission of information on medicinal products by MAH of the Detailed guidance on the electronic submission of information on medicinal products for human use by marketing authorisation holders to the EMA :

Chapter 2 of this detailed guide dives into the various avenues available for marketing authorization holders (MAHs) to electronically submit information on their medicinal products for human use to the European Medicines Agency (EMA). This chapter empowers MAHs to choose the submission method that best suits their needs and technical capabilities.

EudraVigilance Webtrader Post Function: A User-Friendly Portal

The EudraVigilance Webtrader Post Function (Webtrader) serves as a user-friendly web portal specifically designed for submitting information on medicinal products electronically. This platform offers a convenient interface for MAHs to enter and manage their data directly.

Here are some key benefits of using Webtrader:

• Accessibility: Webtrader is accessible from any computer with an internet connection, eliminating the need for dedicated software installation.
• Intuitive Interface: The web-based interface is designed for ease of use, allowing MAHs to navigate the submission process efficiently.
• Real-Time Validation: Webtrader provides real-time validation of the submitted data, ensuring adherence to the required format and data standards.
• Audit Trail: A comprehensive audit trail is automatically generated within Webtrader, documenting all submission actions for future reference.

While Webtrader offers a user-friendly experience, it might not be suitable for large-scale submissions involving numerous medicinal products. In such cases, alternative methods can provide greater efficiency.

eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) Data Entry Tool: Facilitating Bulk Uploads

The eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) data entry tool (EVWEB) offers an alternative approach for MAHs managing a high volume of submissions. EVWEB allows for the bulk upload of product information from an external data source, such as a company database.

Here’s how EVWEB streamlines bulk submissions:

• Data Upload: EVWEB facilitates the upload of product data in a pre-defined format, minimizing manual data entry and reducing the risk of errors.
• Validation and Editing: The tool provides functionalities for data validation and editing before submission, ensuring data quality and compliance with EMA standards.
• Centralized Management: EVWEB allows for the centralized management and oversight of product information for multiple medicinal products.

However, utilizing EVWEB requires a more technical understanding of the data format and submission process compared to Webtrader. MAHs may need to invest in additional resources or collaborate with a technical partner to leverage EVWEB effectively.

Gateway to Gateway (G2G) Communication: Streamlining Integration

For MAHs with established electronic data interchange (EDI) capabilities, Gateway to Gateway (G2G) communication provides a seamless integration with the EMA’s systems. This method allows for automated data exchange between the MAH’s internal systems and the EMA’s EudraVigilance database.

Benefits of G2G communication include:

• Automation: G2G eliminates the need for manual data entry or file transfers, enhancing efficiency and minimizing errors.
• Real-Time Updates: Data exchange occurs in real-time, ensuring the EMA has immediate access to the latest product information.
• Scalability: G2G communication is highly scalable, efficiently handling large volumes of data transmissions for multiple medicinal products.

However, implementing G2G communication requires significant technical expertise and investment in establishing the necessary infrastructure. This method is typically suited for large pharmaceutical companies with extensive IT resources.

Choosing the Right Method

The optimal submission method for an MAH depends on several factors, including:

• Number of Medicinal Products: For a limited number of products, Webtrader’s user-friendly interface might suffice. For a larger portfolio, EVWEB or G2G communication might be more efficient.
• Technical Expertise: MAHs with strong technical capabilities can explore EVWEB or G2G communication. Those lacking such expertise might favor Webtrader’s user-friendly approach.
• Data Management Practices: MAHs with existing data management systems might find G2G communication most efficient for seamless integration.

By carefully considering these factors, MAHs can select the electronic submission method that best aligns with their resources and workflows.

This chapter has presented the various electronic submission avenues available to MAHs. Chapter 3 will delve deeper into the specific data elements required for successful submissions to the EMA.